The potential of using artificial intelligence in drug discovery and development has sparked both excitement and ...

Marea’s Phase IIa study enrolled patients with hypertriglyceridemia—too much fat in the blood. The latest results showed the ...

Researchers at the University of Oklahoma have developed a breakthrough method of adding a single nitrogen atom to molecules, ...

Azafaros B.V. today announced that its lead asset, nizubaglustat, has been granted orphan drug designation from regulatory authorities in both the United States and the European Union for the ...

Denali’s failure on Monday continues biopharma’s losing streak against amyotrophic lateral sclerosis. PTC Therapeutics and ...

Psilocybin is under clinical development by Filament Health and currently in Phase I for Substance (Drug) Abuse.

Learn about Arbutus's promising Hepatitis B treatments, strong financial position, and projections for the global market.

Other Alzheimer's treatments in development that are set for key ... is an investigational small molecule oral drug currently in Phase III clinical studies to test a new approach for the treatment ...

John Kuriyan, dean of basic sciences and University Distinguished Professor of Biochemistry and Chemistry, agreed, adding, ...